CN102698191A - Medicine for removing facial stains - Google Patents
Medicine for removing facial stains Download PDFInfo
- Publication number
- CN102698191A CN102698191A CN2012101456258A CN201210145625A CN102698191A CN 102698191 A CN102698191 A CN 102698191A CN 2012101456258 A CN2012101456258 A CN 2012101456258A CN 201210145625 A CN201210145625 A CN 201210145625A CN 102698191 A CN102698191 A CN 102698191A
- Authority
- CN
- China
- Prior art keywords
- radix
- medicine
- liver
- stains
- mottle
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 22
- 230000001815 facial effect Effects 0.000 title claims abstract description 7
- 229940079593 drug Drugs 0.000 title claims description 6
- 239000002775 capsule Substances 0.000 claims abstract description 10
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims abstract description 6
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims abstract description 6
- 239000000843 powder Substances 0.000 claims abstract description 6
- 230000001954 sterilising effect Effects 0.000 claims abstract description 5
- 229940126680 traditional chinese medicines Drugs 0.000 claims abstract description 3
- 241000628997 Flos Species 0.000 claims description 5
- 108010052008 colla corii asini Proteins 0.000 claims description 5
- 210000000582 semen Anatomy 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 4
- 238000004659 sterilization and disinfection Methods 0.000 claims description 4
- 235000014375 Curcuma Nutrition 0.000 claims description 2
- 244000164439 Curcuma angustifolia Species 0.000 claims description 2
- 241000202807 Glycyrrhiza Species 0.000 claims description 2
- 230000008030 elimination Effects 0.000 claims description 2
- 238000003379 elimination reaction Methods 0.000 claims description 2
- 239000008280 blood Substances 0.000 abstract description 10
- 210000004369 blood Anatomy 0.000 abstract description 10
- 230000000694 effects Effects 0.000 abstract description 8
- 210000004185 liver Anatomy 0.000 abstract description 8
- 230000001737 promoting effect Effects 0.000 abstract description 7
- 230000017531 blood circulation Effects 0.000 abstract description 6
- 210000000952 spleen Anatomy 0.000 abstract description 6
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 abstract description 4
- 238000005728 strengthening Methods 0.000 abstract description 4
- 210000003734 kidney Anatomy 0.000 abstract description 3
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 3
- 244000144730 Amygdalus persica Species 0.000 abstract 1
- 244000020518 Carthamus tinctorius Species 0.000 abstract 1
- 108010010803 Gelatin Proteins 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 235000006040 Prunus persica var persica Nutrition 0.000 abstract 1
- -1 caulis spatholobi Chemical compound 0.000 abstract 1
- 229920000159 gelatin Polymers 0.000 abstract 1
- 239000008273 gelatin Substances 0.000 abstract 1
- 235000019322 gelatine Nutrition 0.000 abstract 1
- 235000011852 gelatine desserts Nutrition 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 238000009499 grossing Methods 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 238000004806 packaging method and process Methods 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 description 6
- 208000003351 Melanosis Diseases 0.000 description 5
- 208000037259 Amyloid Plaque Diseases 0.000 description 3
- 101100117236 Drosophila melanogaster speck gene Proteins 0.000 description 3
- 206010008570 Chloasma Diseases 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 238000002651 drug therapy Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 238000002647 laser therapy Methods 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a medicine prepared based on traditional Chinese medicines for removing facial stains, wherein capsule product is prepared by uniformly mixing Radix Rehmanniae Preparata, donkey-hide gelatin, root of common peony, radix curcumae, peach kernel, radix bupleuri, safflower carthamus, radix paeoniae alba, caulis spatholobi, liquorice, herba leonuri and maltose, which are refined and cleaned with clear water, crushing into 100-120 meshes medicine powder, sterilizing, and packaging into capsules. The medicine provided by the invetion has functions in tonifying the liver and kidney, promoting blood circulation to remove blood stasis, and smoothing liver and strengthening spleen;the treatment effect to stains is significant and the toxic and side effect is small.
Description
Technical field
The present invention relates to a kind of medicine of dispelling stain, relating in particular to a kind of is the medicine of the elimination facial colour spot of crude drug preparation with Chinese medicine.
Background technology
Mottle is exactly the speckle different with ambient color, and mottle comprises freckle, black speck, chloasma and senile plaque etc., belongs to pigment obstacle dermatoses.The morbidity of mottle mainly contains endogenous cause of ill and exopathogenic factor, endogenous cause of ill be mostly what born heredity or endocrine disturbance caused, exopathogenic factor be mostly the life work under bad environment, the life irregular, do not note due to the skin care.The people's that made a difference of mottle orthobiosis, especially harm is bigger concerning Junior Lady.At present mostly mottle efficacious therapy method is laser therapy, but cures the symptoms, not the disease.
Summary of the invention
The purpose of this invention is to provide the medicine that a kind of toxic and side effects is little, therapeutic effect is significantly eliminated facial colour spot.
Medicine of the present invention is that crude drug prepares by following parts by weight of traditional Chinese medicines:
Radix Rehmanniae Preparata 10～20 Colla Corii Asini 10～20 Radix Paeoniae Rubra 10～20 Radix Curcumaes 10～20
Semen Persicae 10～15 Radix Bupleuri 15～25 Flos Carthamis 15～25 Radix Paeoniae Albas 10～15
Caulis Spatholobi 30～50 Radix Glycyrrhizaes 10～20 Herba Leonuris 15～30 maltose 30～50.
The medicine of above-mentioned each component can be processed said peroral dosage form on any pharmaceuticss such as tablet, pill, powder, capsule, and the preferred dosage form of the present invention is a capsule.
The concrete method for preparing of medicine capsule of the present invention is: said medicine by said parts by weight mix homogeneously, is ground into 100～120 purpose medicated powder, makes the capsule product during sterilization incapsulates.
Motherland's medical science thinks, mostly mottle is that stagnation of liver-QI with deficiency of the spleen, deficiency of the liver and kindey do, and depression of liver-QI then QI and blood is not smooth, with the passing of time then gives birth to speckle, and treatment is when with liver and kidney tonifying, blood circulation promoting and blood stasis dispelling, soothing liver and strengthening spleen.In the prescription of the present invention, the Radix Rehmanniae Preparata yin nourishing of enriching blood, life essence-filling, marrow-benefitting; Colla Corii Asini nourishing blood, hemostasis, nourshing Yin and drynsessmoistening prescription; The Radix Paeoniae Rubra clearing away heat and cooling blood, eliminating stasis to stop pain; The Radix Curcumae regulating qi to disperse stagnation, heart fire-clearing upset-relieving; The Semen Persicae blood circulation promoting and blood stasis dispelling, loosening bowel to relieve constipation; Radix Bupleuri is evacuated and is brought down a fever the yang invigorating soothing liver-QI; The Flos Carthami promoting blood circulation to restore menstrual flow, the silt pain relieving of loosing; The Radix Paeoniae Alba yin fluid astringing that nourishes blood, easing the affected liver to relieve pain; The Caulis Spatholobi circulation of qi promoting is enriched blood, soothing the channels and quicking the network vessels
The Radix Glycyrrhizae invigorating the spleen and replenishing QI relaxes the property of medicine; The Herba Leonuri promoting blood flow to regulate menstruation, inducing diuresis to remove edema; Maltose has strengthening the spleen and stomach, lung moistening only dry.All medicines share, and can play the effect of liver and kidney tonifying, blood circulation promoting and blood stasis dispelling, soothing liver and strengthening spleen, and evident in efficacy to the treatment of mottle, toxic and side effects is little.
For further investigating the clinical efficacy of Drug therapy mottle of the present invention, select 65 routine mottle patients to carry out clinical observation on the therapeutic effect.
1, clinical data
65 routine mottle patients all are clinic case, and at minimum 15 years old of age, maximum 65 years old, wherein male 10 examples comprised freckle 5 examples, black speck 2 examples, senile plaque 3 examples; Woman's 55 examples comprise chloasma 25 examples, freckle 15 examples, black speck 5 examples, minimum 15 years old of 5 example ages of senile plaque, and maximum 65 years old, all cases all possessed the clinical symptoms of mottle.
2, Therapeutic Method
Adopt capsule medicine of the present invention, every day 4 times, each 4.
3, criterion of therapeutical effect
Cure: naked eyes are looked the mottle area and are disappeared>90%, color disappears basically;
Produce effects: naked eyes look the mottle area and disappear＞and 60%, color is obviously thin out;
Effectively: naked eyes are looked the mottle cotton knot and are disappeared 30%～60%, and color is thin out;
Invalid: naked eyes look the mottle area and disappear＜and 30%, change color is not obvious;
4, therapeutic effect
The observation of curative effect result sees table 1
Table 1 mottle patient's clinical observation on the therapeutic effect
| The example number | Cure % | Produce effects % | Effective % | Invalid % | Total effective rate % |
| 65 | 20（30.8） | 20（30.8） | 9（13.8） | 16（24.6） | 49（75.4） |
The clinical observation on the therapeutic effect result shows that Drug therapy mottle convenient drug administration of the present invention, evident in efficacy has no side effect, and cure rate is high.
The specific embodiment
Embodiment 1
Get Radix Rehmanniae Preparata 10g, Colla Corii Asini 10 g, Radix Paeoniae Rubra 10 g, Radix Curcumae 10 g, Semen Persicae 10 g, Radix Bupleuri 15 g, Flos Carthami 15g, the Radix Paeoniae Alba 10 g, Caulis Spatholobi 30 g, Radix Glycyrrhizae 10 g, Herba Leonuri 15 g, maltose 30 g mix homogeneously selected, that clear water is cleaned; Be ground into 100～120 medicated powder, make the capsule product during sterilization incapsulates.
Embodiment 2
Get Radix Rehmanniae Preparata 20 g, Colla Corii Asini 20 g, Radix Paeoniae Rubra 20 g, Radix Curcumae 20 g, Semen Persicae 15 g, Radix Bupleuri 25 g, Flos Carthami 25 g, the Radix Paeoniae Alba 15 g, Caulis Spatholobi 50 g, Radix Glycyrrhizae 20 g, Herba Leonuri 30 g, maltose 50 g mix homogeneously selected, that clear water is cleaned; Be ground into 100～120 medicated powder, make the capsule product during sterilization incapsulates.
Claims (2)
1. medicine of eliminating facial colour spot is that crude drug prepares by following parts by weight of traditional Chinese medicines:
Radix Rehmanniae Preparata 10～20 Colla Corii Asini 10～20 Radix Paeoniae Rubra 10～20 Radix Curcumaes 10～20
Semen Persicae 10～15 Radix Bupleuri 15～25 Flos Carthamis 15～25 Radix Paeoniae Albas 10～15
Caulis Spatholobi 30～50 Radix Glycyrrhizaes 10～20 Herba Leonuris 15～30 maltose 30～50.
2. the medicine of elimination facial colour spot according to claim 1 is characterized in that: said medicine by said parts by weight mix homogeneously, is ground into 100～120 purpose medicated powder, makes the capsule product during sterilization incapsulates.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012101456258A CN102698191A (en) | 2012-05-11 | 2012-05-11 | Medicine for removing facial stains |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012101456258A CN102698191A (en) | 2012-05-11 | 2012-05-11 | Medicine for removing facial stains |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102698191A true CN102698191A (en) | 2012-10-03 |
Family
ID=46891438
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012101456258A Pending CN102698191A (en) | 2012-05-11 | 2012-05-11 | Medicine for removing facial stains |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102698191A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103463456A (en) * | 2013-09-22 | 2013-12-25 | 李艳丽 | Traditional Chinese medicine composition and preparation method thereof |
| CN112843155A (en) * | 2021-02-04 | 2021-05-28 | 建昌帮药业有限公司 | Composition suitable for puerpera and used for removing freckles and relieving lumbago |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101856420A (en) * | 2010-06-02 | 2010-10-13 | 贾佳 | Medicament for removing stains and preparation method thereof |
-
2012
- 2012-05-11 CN CN2012101456258A patent/CN102698191A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101856420A (en) * | 2010-06-02 | 2010-10-13 | 贾佳 | Medicament for removing stains and preparation method thereof |
Non-Patent Citations (1)
| Title |
|---|
| 刘桂华等: "调血养颜胶囊治疗气滞血瘀型面部色斑临床观察", 《齐鲁药事》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103463456A (en) * | 2013-09-22 | 2013-12-25 | 李艳丽 | Traditional Chinese medicine composition and preparation method thereof |
| CN112843155A (en) * | 2021-02-04 | 2021-05-28 | 建昌帮药业有限公司 | Composition suitable for puerpera and used for removing freckles and relieving lumbago |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102370949A (en) | Chinese medicinal compound preparation for treating cholecystitis and preparation method thereof | |
| CN104491695A (en) | Pharmaceutical composition for treating chloasma | |
| CN102727779B (en) | Pharmaceutical composition for treating ovarian cysts and preparation method thereof | |
| CN102512617B (en) | Chinese herbal preparation for treating psoriasis | |
| CN104258292A (en) | Drug for department of obstetrics and gynecology for treating pregnancy complication and manufacturing method thereof | |
| CN105362491A (en) | External-use medicine for treating cervical vertebra hyperosteogeny | |
| CN101239134B (en) | Speckle-removing medicinal composition | |
| CN103919966B (en) | A kind of medicine treating acne | |
| CN102698191A (en) | Medicine for removing facial stains | |
| CN102755515B (en) | Traditional Chinese medicine decoction for treating hyperplasia of mammary glands | |
| CN104436048A (en) | Use of traditional Chinese medicine preparation in preparation of medicine for treating qi stagnation and blood stasis type chloasma | |
| CN104138572A (en) | Medicine used for treating chloasma | |
| CN103223048B (en) | Traditional Chinese medicine composition for treating facial leukoderma | |
| CN101129718B (en) | Traditional Chinese medicine preparation for treating leuoderma | |
| CN101085303A (en) | Oral administration traditional Chinese medicine composition for treating hyperplasia of mammary glands | |
| CN104042839A (en) | Traditional Chinese medicine composition for treating tinea versicolor | |
| CN102727740A (en) | Medicine for treating alopecia | |
| CN103830682A (en) | Traditional Chinese medicine composition for treating liver depression and blood stasis syndromes | |
| CN104001140A (en) | Paste for treating PICC (Peripherally Inserted Central Catheter) phlebitis and preparation method thereof | |
| CN103520419B (en) | Medicine for treating globus hysteriocus and preparation method thereof | |
| CN101983712A (en) | Novel medicament for treating coronary heart disease | |
| CN106075268A (en) | A kind of Chinese medicine composition treating scabies | |
| CN1049599C (en) | Medicine for treatment of thromboangiitis obliterans | |
| CN106110121A (en) | A kind of Chinese medicine composition treating tinea versicolor | |
| CN105687359A (en) | Composition for treating chloasma and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| AD01 | Patent right deemed abandoned |
Effective date of abandoning: 20121003 |
|
| C20 | Patent right or utility model deemed to be abandoned or is abandoned |